ArticleClinical rheumatology2024

Increased risk of adverse events among patients with vs. without systemic autoimmune rheumatic disease prescribed sodium-glucose cotransporter 2 inhibitors: a retrospective cohort study.

Emily G Oakes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.